Search research articles
Contact Us
Filters
Showing results (131-140 of 349) with videos related to
Page
of 35
Sort By:
Translational Lung Cancer Research
|
December 3, 2021
Real-time autOmatically updated data warehOuse in healThcare (ROOT): an innovative and automated data collection system
Hyun Ae Jung, Oksoon Jeong, Dong Kyung Chang, et al.
Cancer
|
March 11, 2020
Genomic landscape of acquired resistance to third-generation EGFR tyrosine kinase inhibitors in EGFR T790M-mutant non-small cell lung cancer
Jiyun Lee, Hong Sook Kim, Boram Lee, et al.
Cancer Research and Treatment
|
April 30, 2025
Clinical Relevance of Starting Alectinib at a Reduced Dose in Patients with ALK-Positive Non-Small Cell Lung Cancer
Junkyu Kim, Min-Ji Kim, Jinyong Kim, et al.
Lung Cancer (Amsterdam, Netherlands)
|
December 5, 2013
Clinical characteristics associated with ALK rearrangements in never-smokers with pulmonary adenocarcinoma
Jong-Mu Sun, Maruja Lira, Kinnari Pandya, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery
|
September 13, 2020
Utility of positron emission-computed tomography for predicting pathological response in resectable oesophageal squamous cell carcinoma after neoadjuvant chemoradiation
Jiyun Lee, Joon Young Choi, Sung Won Lim, et al.
Lung Cancer (Amsterdam, Netherlands)
|
March 20, 2019
Repeat biopsy procedures and T790M rates after afatinib, gefitinib, or erlotinib therapy in patients with lung cancer
Kangkook Lee, Youjin Kim, Hyun Ae Jung, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
May 19, 2018
Transient Asymptomatic Pulmonary Opacities During Osimertinib Treatment and its Clinical Implication
Hansang Lee, Ho Yun Lee, Jong-Mu Sun, et al.
Japanese Journal of Clinical Oncology
|
October 28, 2008
Efficacy and toxicity of pemetrexed as a third-line treatment for non-small cell lung cancer
Jong-Mu Sun, Keun-Wook Lee, Jee Hyun Kim, et al.
Cancer
|
January 2, 2024
Immune checkpoint inhibitor use and the incidence of hepatitis B virus reactivation or immune-related hepatitis in non-small cell lung cancer patients with chronic hepatitis B
Joohyun Hong, Jiyun Lee, Sehhoon Park, et al.
Investigational New Drugs
|
July 2, 2011
Sequential therapy with sunitinib and sorafenib in metastatic hepatocellular carcinoma
Hee Kyung Ahn, Soohyeon Lee, Jong-Mu Sun, et al.
Page
of 35
Search research articles
Search
Showing results (131-140 of 349) with videos related to
Sort By:
Page
of 35
Translational Lung Cancer Research
|
December 3, 2021
Real-time autOmatically updated data warehOuse in healThcare (ROOT): an innovative and automated data collection system
Hyun Ae Jung, Oksoon Jeong, Dong Kyung Chang, et al.
Cancer
|
March 11, 2020
Genomic landscape of acquired resistance to third-generation EGFR tyrosine kinase inhibitors in EGFR T790M-mutant non-small cell lung cancer
Jiyun Lee, Hong Sook Kim, Boram Lee, et al.
Cancer Research and Treatment
|
April 30, 2025
Clinical Relevance of Starting Alectinib at a Reduced Dose in Patients with ALK-Positive Non-Small Cell Lung Cancer
Junkyu Kim, Min-Ji Kim, Jinyong Kim, et al.
Lung Cancer (Amsterdam, Netherlands)
|
December 5, 2013
Clinical characteristics associated with ALK rearrangements in never-smokers with pulmonary adenocarcinoma
Jong-Mu Sun, Maruja Lira, Kinnari Pandya, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery
|
September 13, 2020
Utility of positron emission-computed tomography for predicting pathological response in resectable oesophageal squamous cell carcinoma after neoadjuvant chemoradiation
Jiyun Lee, Joon Young Choi, Sung Won Lim, et al.
Lung Cancer (Amsterdam, Netherlands)
|
March 20, 2019
Repeat biopsy procedures and T790M rates after afatinib, gefitinib, or erlotinib therapy in patients with lung cancer
Kangkook Lee, Youjin Kim, Hyun Ae Jung, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
May 19, 2018
Transient Asymptomatic Pulmonary Opacities During Osimertinib Treatment and its Clinical Implication
Hansang Lee, Ho Yun Lee, Jong-Mu Sun, et al.
Japanese Journal of Clinical Oncology
|
October 28, 2008
Efficacy and toxicity of pemetrexed as a third-line treatment for non-small cell lung cancer
Jong-Mu Sun, Keun-Wook Lee, Jee Hyun Kim, et al.
Cancer
|
January 2, 2024
Immune checkpoint inhibitor use and the incidence of hepatitis B virus reactivation or immune-related hepatitis in non-small cell lung cancer patients with chronic hepatitis B
Joohyun Hong, Jiyun Lee, Sehhoon Park, et al.
Investigational New Drugs
|
July 2, 2011
Sequential therapy with sunitinib and sorafenib in metastatic hepatocellular carcinoma
Hee Kyung Ahn, Soohyeon Lee, Jong-Mu Sun, et al.
Page
of 35